Insulet (Nasdaq:PODD) announced today that it commenced the full market launch for its next-generation Omnipod 5 system.
The Omnipod 5 automated insulin delivery (AID) system has now been made fully available through U.S. retail pharmacy channels for individuals aged six years and older with type 1 diabetes.
Get the full story at our sister site, Drug Delivery Business News.